-
The NIH has halted the estrogen-alone wing of the Womens Health Initiative a year before its scheduled end.
-
-
Optimizing outcomes in patients with acute coronary syndrome requires matching patients with strategies that will produce the best results in specific clinical subgroups. Identifying those patients with ST elevation myocardial infarction (STEMI) who represent ideal candidates for fibrinolysis, and who are likely to have outcomes that are at least as favorable as they would have with percutaneous interventions, has become an area of intense focus among cardiologists and emergency physicians. Significant improvements in patient outcomes will be made when patients are managed according to their institutional capabilities, with the understanding that prompt thrombolysis in the setting of STEMI is fundamental to optimal patient care. This article, the second in a two-part series, provides a practical, evidence-based approach to comprehensive management of this patient population.
-
Migraine and Subclinical Brain Lesions; Memantine Treatment in Alzheimer Disease; PPG in Type 2 DM
-
The FDA has approved the first antineoplastic that acts by the inhibiting the formation of new blood vessels in tumors.
-
Use of antibiotics is associated with increased risk of breast cancer and death from breast cancer in a dose-dependent way.
-
-
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera; Coronary Artery Calcium Score Plus Framingham Score for Risk Prediction; Intra-Articular Hyaluronic Acid in the Treatment of Knee Osteoarthritis
-
The FDA has approved a combination of olanzapine and fluoxetine for the treatment of depressive episodes associated with bipolar disorder.
-
Intranasal fluticasone helps sleep-disordered breathing in patients with allergic rhinitis.
